Students travel the continent to volunteer during spring break

Nearly 200 WUSTL students will volunteer their time throughout the continent during spring break, March 8-12. Dozens of groups of students will travel to places as close as Chicago and as far away as Guatemala City, Guatemala, for service projects ranging from building construction and maintenance to helping at an orphanage.

Die Fledermaus opens March 19 and 20

Over the past two decades Jolly Stewart has been a force in St. Louis opera. Friday and Saturday, March 19 and 20, the Washington University Opera will celebrate Stewart’s upcoming retirement with an “all-star” performance of Die Fledermaus, the beloved operetta by Johann Strauss II. The production will feature nine returning alumni — all of whom sing professionally — as well as celebrated baritone Ian Greenlaw, teacher of applied music in Arts & Sciences.

Others may know us better than we know ourselves, study finds

Humans have long been advised to “know thyself,” but new research suggests we may not know ourselves as well as we think we do. While individuals may be more accurate at assessing their own neurotic traits, such as anxiety, it seems friends, and even strangers, are often better barometers of traits such as intelligence, creativity and extroversion.

Senior wins Luce Scholarship

Senior Alex Baron, majoring in philosophy-neuroscience-psychology and in political science, both in Arts & Sciences, has won a prestigious Luce Scholarship. He is one of 18 scholars chosen nationwide.

Brookings and WUSTL announce Academic Venture Fund grant recipients

The Brookings Institution and Washington University in St. Louis announce the first recipients of grants from the Academic Venture Fund, the purpose of which is  to support collaboration between the two institutions, particularly long-term projects that impact research, education and policy. Grants are available in amounts from $20,000 to $50,000. Interested fellows, faculty, staff, centers, institutes and programs can submit proposals by June 1 for review in July 2010. 

New subtype of breast cancer responds to targeted drug

A newly identified cancer biomarker could define a new subtype of breast cancer as well as offer a potential way to treat it, say researchers at Washington University School of Medicine in St. Louis. The biomarker is found frequently in breast cancers that have poorer outcomes and can be inhibited by a protein discovered in the same laboratory, which could become an effective drug against the breast cancer type.
View More Stories